|Day's Range||1.12 - 1.20|
|52 Week Range||1.12 - 12.00|
|PE Ratio (TTM)||-0.16|
|Earnings Date||Aug 21, 2017 - Aug 25, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||5.00|
LOS ANGELES, CA / ACCESSWIRE / May 26, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular" or the "Company") ...
NEW YORK, NY / ACCESSWIRE / May 26, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of ImmunoCellular ...
IRVINE, Calif., May 25, 2017-- Khang & Khang LLP announces a securities class action lawsuit against ImmunoCellular Therapeutics, Ltd.. Investors who purchased or otherwise acquired shares between May ...